Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06546202
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China A Retrospective Database Multi-center Study ReTARdant
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to investigate the pharmacological treatment pattern among patients with diabetic peripheral neuropathic pain DPNP and chemotherapy-induced peripheral neuropathy CIPN in China
Detailed Description:
Diabetic peripheral neuropathic pain DPNP and chemotherapy-induced peripheral neuropathy CIPN are common subtypes of neuropathic pain The treatment pattern subsequent medication usage and compliance information of medication among these patients are still not clear There is also an unmet need for the use of relevant analgesic medications in this area This real-world data study aims to understand patients characteristics clinical diagnosis and treatment patterns medication compliance real-world effectiveness among DPNP and CIPN patients in China and will explore the current unmet needs of DPNP and CIPN in order to inform physicians decision-making in clinical practice
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None